Scientists at the Psychedelic Research Unit of Johns Hopkins start a clinical trial pilot study to evaluate the effects of psilocybin-assisted therapy for treating anorexia nervosa (AN). This study demonstrates the increasing interest in researching the therapeutic applications of psychedelic drugs. The AN clinical trial comes on the heels of the US Food and Drug Administration (FDA) granting breakthrough therapy designation for the psilocybin-assisted therapy clinical trial for treatment-resistant depression that is currently underway.